Table 2.
Impact of 6 (T2) months of intervention on nuclear anomalies in buccal cells.
| Intervention | RT |
RTS |
CT |
||||||
|---|---|---|---|---|---|---|---|---|---|
| T1 | T2 | P | T1 | T2 | P | T1 | T2 | P | |
| Subjects [number] | 29 | 29 | 27 | 27 | 31 | 31 | |||
| MN cells [per 1000 diff. cells] | 1.25 ± 0.45 | 1.31 ± 0.62 | 0.673 | 1.24 ± 0.47 | 1.22 ± 0.51 | 0.840 | 1.12 ± 0.35 | 1.13 ± 0.65 | 0.878 |
| MN total [per 1000 diff. cells] | 1.35 ± 0.46 | 1.55 ± 0.63 | 0.071 | 1.41 ± 0.50 | 1.09 ± 1.85 | 0.119 | 1.18 ± 0.39 | 1.31 ± 0.69 | 0.250 |
| Nuclear buds [per 1000 diff. cells] | 1.22 ± 0.81 | 1.31 ± 0.75 | 0.797 | 1.20 ± 0.97 | 1.16 ± 0.68 | 0.563 | 1.03 ± 0.75 | 1.03 ± 0.76 | 0.982 |
| Binucleated cells [per 1000 diff. cells] | 26.1 ± 9.6 | 28.7 ± 9.5 | 0.066 | 24.9 ± 7.4 | 25.5 ± 9.3 | 0.828 | 22.7 ± 8.0 | 25.3 ± 7.8 | 0.052 |
| Karyorrhectic cells [per 1000 cells] | 22.9 ± 9.8 | 25.3 ± 9.1 | 0.105 | 24.1 ± 8.7 | 26.3 ± 7.5 | 0.071 | 22.5 ± 10.7 | 25.1 ± 11.0 | 0.072 |
| Karyolytic cells [per 1000 cells] | 59.8 ± 26.8 | 62.9 ± 27.2 | 0.385 | 55.4 ± 22.8 | 54.1 ± 21.1 | 0.691 | 66.5 ± 25.3 | 67.1 ± 24.6 | 0.717 |
| Pyknotic cells [per 1000 cells] | 1.38 ± 1.15 | 1.55 ± 1.06 | 0.373 | 0.89 ± 0.80 | 1.07 ± 0.73 | 0.330 | 1.45 ± 0.99 | 1.35 ± 0.84 | 0.528 |
Data are means ± SD; p-values were calculated using Wilcoxon-Test. Only data from the Vienna Active Ageing Study were used for the analyses.